{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T03:21:50Z","timestamp":1773717710728,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,10]]},"DOI":"10.7759\/cureus.19450","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T02:02:38Z","timestamp":1636596158000},"source":"Crossref","is-referenced-by-count":3,"title":["Isolated Ocular Manifestations in Chronic Myeloid Leukaemia"],"prefix":"10.7759","author":[{"given":"Anita","family":"Maniam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanis","family":"Zuhaimy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca Martina M","family":"Vendargon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Othmaliza","family":"Othman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.76.11.651","article-title":"Prognostic importance of ophthalmic manifestations in childhood leukaemia","volume":"76","author":"Ohkoshi K","year":"1992","unstructured":"Ohkoshi K, Tsiaras WG. Prognostic importance of ophthalmic manifestations in childhood leukaemia. Br J Ophthalmol. 1992, 76:651-5. 10.1136\/bjo.76.11.651","journal-title":"Br J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(89)32809-0","article-title":"Leukaemic retinopathy. Relationship between fundus lesions and haematologic parameters at diagnosis","volume":"96","author":"Guyer DR","year":"1989","unstructured":"Guyer DR, Schachat AP, Vitale S, et al.. Leukaemic retinopathy. Relationship between fundus lesions and haematologic parameters at diagnosis. Ophthalmology. 1989, 96:860-864. 10.1016\/s0161-6420(89)32809-0","journal-title":"Ophthalmology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5851.125266","article-title":"Ischaemic optic neuropathy induced sudden blindness as an initial presentation of acute lymphoblastic leukemia","volume":"34","author":"Chaudhuri T","year":"2013","unstructured":"Chaudhuri T, Roy S, Roy P. Ischaemic optic neuropathy induced sudden blindness as an initial presentation of acute lymphoblastic leukemia. Indian J Med Paediatr Oncol. 2013, 34:335-6. 10.4103\/0971-5851.125266","journal-title":"Indian J Med Paediatr Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.169789","article-title":"Ophthalmic manifestations of acute and chronic leukemias presenting to a tertiary care center in India","volume":"63","author":"Koshy J","year":"2015","unstructured":"Koshy J, John MJ, Thomas S, Kaur G, Batra N, Xavier WJ. Ophthalmic manifestations of acute and chronic leukemias presenting to a tertiary care center in India. Indian J Ophthalmol. 2015, 63:659-64. 10.4103\/0301-4738.169789","journal-title":"Indian J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/01.iae.0000258271.36131.d3","article-title":"Bilateral proliferative retinopathy in chronic myelogenous leukemia","volume":"27","author":"Huynh TH","year":"2007","unstructured":"Huynh TH, Johnson MW, Hackel RE. Bilateral proliferative retinopathy in chronic myelogenous leukemia. Retina. 2007, 27:124-5. 10.1097\/01.iae.0000258271.36131.d3","journal-title":"Retina"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1600-0420.2003.00197.x","article-title":"Retinopathy in acute leukaemia at initial diagnosis: correlation of fundus lesions and haematological parameters","volume":"82","author":"Reddy SC","year":"2004","unstructured":"Reddy SC, Jackson N. Retinopathy in acute leukaemia at initial diagnosis: correlation of fundus lesions and haematological parameters. Acta Ophthalmol Scand. 2004, 82:81-5. 10.1046\/j.1600-0420.2003.00197.x","journal-title":"Acta Ophthalmol Scand"},{"key":"ref7","article-title":"","author":"Miller NR","year":"2005","unstructured":"Miller NR, Walsh FB, Hoyt WF. Walsh and Hoyt's Clinical Neuro-Ophthalmology. Lippincott Williams & Wilkins, \tPhiladelphia; 2005. https:\/\/books.google.com.my\/books?hl=en&lr=&id=LlScNoY3vp8C&oi=fnd&pg=PA1335&dq=Walsh+and+Hoyt%27s+Clinical+Neuro-Oph...."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/380451","article-title":"Isolated ocular manifestation of relapsed chronic myelogenous leukemia presenting as myeloid blast crisis in a patient on imatinib therapy: a case report and review of the literature","volume":"2015","author":"Gulati R","year":"2015","unstructured":"Gulati R, Alkhatib Y, Donthireddy V, Felicella MM, Menon MP, Inamdar KV. Isolated ocular manifestation of relapsed chronic myelogenous leukemia presenting as myeloid blast crisis in a patient on imatinib therapy: a case report and review of the literature. Case Rep Pathol. 2015, 2015:380451. 10.1155\/2015\/380451","journal-title":"Case Rep Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-021-02097-w","article-title":"Complete reversal of bilateral optic nerve infiltration from lymphoblastic leukemia using chemotherapy without adjuvant radiotherapy","volume":"21","author":"da Costa DR","year":"2021","unstructured":"da Costa DR, Fernandes RD, Susanna FN, da Silva Neto ED, Monteiro ML. Complete reversal of bilateral optic nerve infiltration from lymphoblastic leukemia using chemotherapy without adjuvant radiotherapy. BMC Ophthalmol. 2021, 21:335. 10.1186\/s12886-021-02097-w","journal-title":"BMC Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6700701","article-title":"Leukaemic infiltration of the optic nerve as the initial manifestation of leukaemic relapse","volume":"18","author":"Lin YC","year":"2004","unstructured":"Lin YC, Wang AG, Yen MY, Hsu WM. Leukaemic infiltration of the optic nerve as the initial manifestation of leukaemic relapse. Eye (Lond). 2004, 18:546-50. 10.1038\/sj.eye.6700701","journal-title":"Eye (Lond)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199107183250315","article-title":"Successful treatment with hydroxyurea of ocular involvement in chronic myelomonocytic leukemia","volume":"325","author":"Wolff-Kormann PG","year":"1991","unstructured":"Wolff-Kormann PG, Hasenfratz BC, Heinrich B, Kormann B. Successful treatment with hydroxyurea of ocular involvement in chronic myelomonocytic leukemia. N Engl J Med. 1991, 325:209-10. 10.1056\/NEJM199107183250315","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609324","article-title":"Long-term outcomes of imatinib treatment for chronic myeloid leukemia","volume":"376","author":"Hochhaus A","year":"2017","unstructured":"Hochhaus A, Larson RA, Guilhot F, et al.. Long-term outcomes of imatinib treatment for chronic myeloid leukemia. N Engl J Med. 2017, 376:917-27. 10.1056\/NEJMoa1609324","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-007-9352-0","article-title":"Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: a case report","volume":"84","author":"Altintas A","year":"2007","unstructured":"Altintas A, Cil T, Kilinc I, Kaplan MA, Ayyildiz O. Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: a case report. J Neurooncol. 2007, 84:103-5. 10.1007\/s11060-007-9352-0","journal-title":"J Neurooncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(02)01964-5","article-title":"Resolution of leukemic retinopathy following treatment with imatinib mesylate for chronic myelogenous leukemia","volume":"135","author":"John BC","year":"2003","unstructured":"John BC, Daniel JD, Donald JD. Resolution of leukemic retinopathy following treatment with imatinib mesylate for chronic myelogenous leukemia. American Journal of Ophthalmology. 2003, 135:398-400. 10.1016\/s0002-9394(02)01964-5","journal-title":"American Journal of Ophthalmology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2021.07.001","article-title":"Ophthalmologic manifestations as the initial presentation of chronic myeloid leukemia: a review [PREPRINT]","author":"Yassin MA","year":"2021","unstructured":"Yassin MA, Ata F, Mohamed SF, et al.. Ophthalmologic manifestations as the initial presentation of chronic myeloid leukemia: a review [PREPRINT]. Surv Ophthalmol. 2021, 10.1016\/j.survophthal.2021.07.001","journal-title":"Surv Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-03-0155","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates","volume":"10","author":"Neville K","year":"2004","unstructured":"Neville K, Parise RA, Thompson P, et al.. Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates. Clin Cancer Res. 2004, 10:2525-9. 10.1158\/1078-0432.ccr-03-0155","journal-title":"Clin Cancer Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1021\/jm049486a","article-title":"Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src\/Abl kinase inhibitor with potent antitumor activity in preclinical assays","volume":"47","author":"Lombardo LJ","year":"2004","unstructured":"Lombardo LJ, Lee FY, Chen P, et al.. Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src\/Abl kinase inhibitor with potent antitumor activity in preclinical assays. J Med Chem. 2004, 47:6658-61. 10.1021\/jm049486a","journal-title":"J Med Chem"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2010.509453","article-title":"Dasatinib is effective against optic nerve infiltration of Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"51","author":"Satake A","year":"2010","unstructured":"Satake A, Okada M, Asada T, et al.. Dasatinib is effective against optic nerve infiltration of Philadelphia chromosome-positive acute lymphoblastic leukemia. Leuk Lymphoma. 2010, 51:1920-2. 10.3109\/10428194.2010.509453","journal-title":"Leuk Lymphoma"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/ICB.0000000000000187","article-title":"Leukemic optic nerve infiltration in a patient with acute lymphoblastic leukemia","volume":"10","author":"Nagpal MP","year":"2016","unstructured":"Nagpal MP, Mehrotra NS, Mehta RC, Shukla CK. Leukemic optic nerve infiltration in a patient with acute lymphoblastic leukemia. Retin Cases Brief Rep. 2016, 10:127-30. 10.1097\/ICB.0000000000000187","journal-title":"Retin Cases Brief Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58654-8","article-title":"Ocular manifestations of leukemia and results of treatment with intravitreal methotrexate","volume":"10","author":"Vishnevskia-Dai V","year":"2020","unstructured":"Vishnevskia-Dai V, Sella King S, Lekach R, Fabian ID, Zloto O. Ocular manifestations of leukemia and results of treatment with intravitreal methotrexate. Sci Rep. 2020, 10:1994. 10.1038\/s41598-020-58654-8","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/71760-isolated-ocular-manifestations-in-chronic-myeloid-leukaemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:20Z","timestamp":1707507380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/71760-isolated-ocular-manifestations-in-chronic-myeloid-leukaemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,10]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.19450","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,10]]}}}